Asset Management One
ONC

Asset Management One’s BeOne Medicines Ltd ONC Stock Holding History

Asset Management One’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.08M Hold
21,346
– – 0.02% 574
2026
Q1 		$6.34M Buy
21,346
+1,348
+7% +$436K 0.02% 551
2025
Q4 		$6.21M Buy
19,998
+88
+0.4% +$28.8K 0.02% 575
2025
Q3 		$6.78M Sell
19,910
-543
-3% -$165K 0.02% 549
2025
Q2 		$4.95M Hold
20,453
– – 0.02% 605
2025
Q1 		$5.57M Hold
20,453
– – 0.02% 583
2024
Q4 		$3.72M Hold
20,453
– – 0.01% 664
2024
Q3 		$4.59M Buy
20,453
+2,593
+15% +$467K 0.02% 629
2024
Q2 		$2.55M Hold
17,860
– – 0.01% 714
2024
Q1 		$2.79M Hold
17,860
– – 0.01% 709
2023
Q4 		$3.21M Hold
17,860
– – 0.01% 701
2023
Q3 		$3.21M Hold
17,860
– – 0.01% 693
2023
Q2 		$3.18M Buy
17,860
+1,377
+8% +$317K 0.01% 706
2023
Q1 		$3.55M Hold
16,483
– – 0.02% 673
2022
Q4 		$3.69M Sell
16,483
-10,972
-40% -$2.01M 0.02% 646
2022
Q3 		$3.7M Buy
27,455
+1,635
+6% +$281K 0.02% 639
2022
Q2 		$4.18M Sell
25,820
-130
-0.5% -$20.3K 0.02% 635
2022
Q1 		$4.89M Buy
25,950
+995
+4% +$212K 0.02% 642
2021
Q4 		$6.51M Sell
24,955
-2,414
-9% -$815K 0.02% 598
2021
Q3 		$9.93M Buy
27,369
+386
+1% +$126K 0.04% 475
2021
Q2 		$9.26M Sell
26,983
-1,248
-4% -$413K 0.03% 505
2021
Q1 		$9.83M Sell
28,231
-717
-2% -$237K 0.04% 471
2020
Q4 		$7.09M Sell
28,948
-243
-0.8% -$66.9K 0.03% 554
2020
Q3 		$8.36M Buy
29,191
+78
+0.3% +$18.3K 0.04% 439
2020
Q2 		$5.49M Buy
29,113
+2,271
+8% +$370K 0.03% 541
2020
Q1 		$3.3M Buy
26,842
+340
+1% +$53.2K 0.02% 606
2019
Q4 		$4.39M Buy
26,502
+821
+3% +$136K 0.02% 659
2019
Q3 		$3.15M Buy
25,681
+277
+1% +$36.8K 0.02% 726
2019
Q2 		$3.15M Buy
25,404
+2,070
+9% +$263K 0.02% 736
2019
Q1 		$3.08M Sell
23,334
-29,432
-56% -$3.97M 0.02% 709
2018
Q4 		$7.4M Buy
+52,766
New +$7M 0.02% 644

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Asset Management One's ONC Position: Q2 2026 in Review

Asset Management One held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 21,346 shares worth $6.08M. The position accounts for 0.02% of the portfolio, ranked #574.

Asset Management One first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.93M in Q3 2021. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Asset Management One held 21,346 shares of BeOne Medicines Ltd worth $6.08M as of Q2 2026.
  • Asset Management One left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.02% of Asset Management One's portfolio in Q2 2026, its #574 holding.
  • Asset Management One first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
  • Asset Management One's BeOne Medicines Ltd position peaked at $9.93M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.